Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Refractory Non-Hodgkin Lymphoma Clinical Trials

2 recruiting trials for Refractory Non-Hodgkin Lymphoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT06026319

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory Non-Hodgkin Lymphoma and to understand the side effects when treated...

Sponsor: Marcela V. Maus, M.D.,Ph.D.Enrolling: 241 location
RECRUITINGPhase 1NCT05077527

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

This phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on treating patients with...

Sponsor: AIDS Malignancy ConsortiumEnrolling: 205 locations